Perrigo Co. PLC has "big fundamental issues" slowing its earnings growth even though its sales of private label and store brand OTC drugs outpace national brands' sales, says President and CEO Murray Kessler.
"Probably the worst offense" among Perrigo's problems, Kessler said on Jan
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?